For each gene combination, the patients were classified into high-or low-expressing groups according to whether the expression of the candidate gene was greater or smaller than the median expression of the candidate gene. The x-axis shows either time to first recurrence/metastasis or time to death in days; the y-axis shows proportion without progression. Progression is defined as metastasis recurrence or progression at the initial tumor site. For ease of comparisons in combination plots, individual P values have been depicted underneath the survival plots. P value significance, P < 0.1. Note that the CEA gene is referred to CEACAM5 in the new nomenclature. However, given the retention of the CEA name in CEACAM research community, we have used the original name i.e. CEA throughout the current study except in the TCGA results section where CEACAM5 is the given name in TCGA database. T3-T4 T1-T4 T3-T4 T1-T4 T3-T4 T1-T4 T3-T4 T1- 
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